ATMA CENA Practitioners

ATMA CENA Practitioners Psychedelic & Ketamine Therapy training, clinical trials, & guiding you from training to practice in clinics across Canada through our CoCare Program

ATMA was the first private company in Canada to conduct legal psychedelic-assisted therapy with psilocybin, one of the active hallucinogens found in 'magic mushrooms'. For more information, visit www.atmajourney.com. OUR VISION:
A world where each individual is empowered to explore, optimize and heal themselves and their community through evidence-based science and the inner intelligence of psyche

delics. OUR MISSION:
To bring the healing and transformative power of psychedelic medicine and psychedelic-assisted therapy to the world.

There's an ongoing conversation in the psychedelic therapy field about how much the surrounding therapeutic support actu...
04/24/2026

There's an ongoing conversation in the psychedelic therapy field about how much the surrounding therapeutic support actually matters — and a new meta-analysis is offering some of the clearest data yet.

Published in JAMA Network Open in January 2026, the study analyzed controlled clinical trials investigating psychedelic-assisted therapy for depressive symptoms. Researchers examined whether the quantity of preparation and integration therapy — the sessions that happen before and after the psychedelic experience — was associated with better outcomes.

The finding on preparation was statistically significant: more preparation time was associated with meaningfully larger reductions in depressive symptoms.

This has real implications for how PAT programs are designed and delivered. It supports the clinical instinct that the container around the experience is not incidental — it's therapeutic in its own right. Building trust, setting intention, reducing anxiety, and establishing a safe relational foundation before a session doesn't just make the experience more comfortable. It may directly shape how much benefit a client walks away with.

For therapists and clinicians working in this space, it's compelling evidence that the work happening before the session deserves the same investment as the session itself.

Read the full article at https://pubmed.ncbi.nlm.nih.gov/41563753/

preparation sessions | psychedelic-assisted therapy | PAT | meta-analysis | antidepressant outcomes

Big news. Evidence in Practice: Implementing KAT in Indigenous Health Services is officially published in FrontiersThis ...
04/22/2026

Big news.

Evidence in Practice: Implementing KAT in Indigenous Health Services is officially published in Frontiers

This one means a lot. It's the result of a genuine collaboration between ATMA CENA and Siksika Health Services — built around what it actually looks like to deliver innovative mental health care that's culturally grounded, community-led, and clinically sound.

Huge thank you to our team members for their authorship & contributions, and to everyone across the org who held things together while this pilot was running — clinical, operations, scheduling, all of it. This belongs to the whole team.

So excited to see it out in the world.

https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2026.1722573/full

Not sure where to begin when clients ask about psychedelic-assisted therapy? ATMA CENA built tools for therapists learni...
04/22/2026

Not sure where to begin when clients ask about psychedelic-assisted therapy? ATMA CENA built tools for therapists learning to navigate complex client conversations safely & ethically.

We put together a free Therapist Starter Kit: two clinical tools that give you a grounded, practical entry point into the PAT framework, before you commit to any formal training.

A lot of therapists are asking the same questions right now. Is this evidence-based? What does the clinical model actually look like? How does this fit into an existing practice? In other words... where do I begin, or tell my clients to begin?
The Starter Kit will give you something real to work with.

It's free. It takes minutes to access. And it's designed by clinicians who practice in this space every day.
Access the free Starter Kit at atmacena.com

PAT | therapist training | free clinical tools | ATMA CENA | psychedelic-assisted therapy

Every advanced pathway at ATMA CENA — Clinical, Prescriber, and Integrative — starts with PAT Foundations.This is the co...
04/20/2026

Every advanced pathway at ATMA CENA — Clinical, Prescriber, and Integrative — starts with PAT Foundations.

This is the course that gives you the grounded, comprehensive knowledge to move into specialized clinical work with confidence.

What you'll build:
✓ History and science of psychedelic medicine
✓ Core therapeutic frameworks for PAT
✓ Ethics, safety, and scope of practice
✓ Preparation and integration fundamentals

13 CE credits | 100% online

Registration deadline: May 30th, 2026

This is where the work begins.

👉 Enroll or speak with an advisor: atmacena.com/courses/psychedelic-assisted-therapy-foundations

If medication hasn't been working — or if side effects have made it hard to stay consistent — rTMS may be worth understa...
04/20/2026

If medication hasn't been working — or if side effects have made it hard to stay consistent — rTMS may be worth understanding.

Repetitive Transcranial Magnetic Stimulation (rTMS) uses targeted magnetic pulses to stimulate areas of the brain involved in mood regulation. It's non-invasive, performed in a clinical setting, and requires no sedation or downtime.

rTMS is Health Canada approved and has been studied across a range of mental health conditions — including depression, anxiety, OCD, and PTSD — particularly in people who haven't responded well to medication alone.

Sessions are typically 20–40 minutes. Most courses of treatment run over several weeks. You can drive yourself home after.

At ATMA CENA, rTMS is part of a broader approach to mental health care that looks beyond medication as the only option.

Learn more at atmacena.com

rTMS | non-invasive therapy | mental health treatment | ATMA | medication-free

On April 19, 1943, Dr. Albert Hofmann became the first person to intentionally experience the effects of L*D — and he do...
04/19/2026

On April 19, 1943, Dr. Albert Hofmann became the first person to intentionally experience the effects of L*D — and he documented the whole thing. Every sensation. Every colour. Every distortion of space and time. With a scientist's eye.

What followed wasn't just a wild ride. It was the beginning of decades of research into consciousness, neuroplasticity, and the therapeutic potential of psychedelic compounds — research that is now experiencing a long-overdue renaissance.

Today, we celebrate Bicycle Day: the moment curiosity, courage, and rigorous observation opened a door that's still being explored.

At ATMA CENA, that spirit of inquiry is at the heart of everything we do. The science has evolved. The protocols are safer. The understanding is deeper. And the potential — for real, lasting healing — is becoming harder to ignore.

Here's to the researchers, the clinicians, and the patients willing to explore what conventional medicine has left behind.

🚲 Happy Bicycle Day.

Bicycle Day | Psychedelic Science | Albert Hofmann | Psychedelic Therapy | Consciousness Science

If you've been watching this field evolve and wondering how to get involved — this is the entry point for every advanced...
04/17/2026

If you've been watching this field evolve and wondering how to get involved — this is the entry point for every advanced pathway, designed as the first step into the future of mental healthcare.

Our next registration deadline is May 15th. Join the movement.

Learn more at atmacena.com/psychedelic-therapy-training

PAT Foundations | therapist training | psychedelic-assisted therapy | ATMA CENA

In psychedelic therapy, a lot of people focus most on the medically supervised session.But what happens after is equally...
04/15/2026

In psychedelic therapy, a lot of people focus most on the medically supervised session.
But what happens after is equally important (or moreso!)

Integration therapy is the structured support that follows a psychedelic-assisted session. It's where you and your therapist work through what emerged — the emotions, images, memories, and realizations — and figure out what they mean for your life.

Without integration, insights can fade. Or worse, they can feel disorienting without a framework to make sense of them.

In our books, integration is anything but an afterthought. It's a core part of the clinical process. Your therapist is trained to help you translate the experience into something actionable — new patterns, new perspectives, and real movement in your mental health.

The session opens a door. Integration is how you walk through it.

Learn more about Integration at atmacena.com

integration therapy | psychedelic assisted therapy | ATMA CENA | psychological healing

Not everything that looks like healing is moving you forward.There's a pattern that experienced clinicians are starting ...
04/13/2026

Not everything that looks like healing is moving you forward.

There's a pattern that experienced clinicians are starting to name more openly: clients who become attached to the experience of doing the work — seeking the next session, the next ceremony, the next profound moment — rather than doing the slower, less dramatic work of actually integrating what they've already learned.

The insights were real. The sessions were meaningful. But somewhere along the way, the healing journey itself became a place to stay instead of a path to walk.

This isn't a failure of the medicine or the modality. It's a human pattern — the same way someone can spend years in talk therapy processing the same story without it ever changing. Seeking depth of experience can quietly substitute for the harder work of showing up differently in daily life.

Real integration is often unglamorous. It looks like a difficult conversation you finally have. A boundary you hold. A pattern you catch yourself in and choose differently. It builds a life — it doesn't require you to keep returning to the room.

At ATMA CENA, integration is clinically structured and intentionally boundaried. The goal isn't ongoing reliance on the therapeutic process. It's building the internal capacity to not need it.

Learn more at atmacena.com

integration therapy | psychedelic integration | healing | psychedelic-assisted therapy | mental health

04/10/2026

For practitioners ready to understand psychedelic-assisted therapy from the inside out. Our first cohort is this weekend, here’s the set up!

The Immersive is a clinical, in-person experience designed for ATMA CENA-trained practitioners who want to move through the full arc of care — from preparation through dosing and integration — as both clinician and participant.

This is a lived experience that deepens your capacity to hold space, set intention, and guide integration with real insight.

Hosted in Calgary with a cohort of 10.
Next available cohort: June 2026.

Enrollment involves clinical screening and approval. Link in bio to review details and book a call with our student advisor.

One of the most meaningful challenges in treating depression — particularly treatment-resistant depression — is the gap ...
04/10/2026

One of the most meaningful challenges in treating depression — particularly treatment-resistant depression — is the gap between what works in research settings and what's actually accessible to patients in clinical practice. Duration of effect, time in clinic, tolerability, and scalability all matter.

That's part of what makes the emerging data from AtaiBeckley's BPL-003 program worth paying attention to.

BPL-003 is a novel synthetic intranasal psychedelic formulation currently under clinical investigation for treatment-resistant depression. In a Phase 2a open-label study, a single dose produced a rapid antidepressant response in 55% of patients by Day 1, with 55% in remission at Day 29 and 45% still in remission at Day 85. Average time in clinic was under two hours.

These are early-stage results — the formulation is still in clinical development, with Phase 2b trials underway — but the data contributes to a growing body of evidence examining shorter-acting, clinically administered psychedelic compounds as a viable pathway for people who haven't responded to conventional care.

The science is moving. We're watching it closely.

Read more at https://clinicaltrials.gov/study/NCT05660642

intranasal psychedelic | BPL-003 | treatment-resistant depression | AtaiBeckley | clinical trial

Here's research that surprised even us: scientists are exploring whether psychedelic therapy could treat Irritable Bowel...
04/08/2026

Here's research that surprised even us: scientists are exploring whether psychedelic therapy could treat Irritable Bowel Syndrome (IBS). Strange connection? Not when you understand the gut-brain axis.

Your digestive system contains more neurotransmitters than your brain, earning it the nickname "second brain." IBS often correlates with anxiety, trauma, and nervous system dysregulation—exactly the conditions psychedelics have shown promise treating. If psychedelics help regulate the nervous system and reduce chronic stress responses, it makes sense they might impact gut health too.
This research is early stage, but it exemplifies the potential for psychedelic medicine to address conditions far beyond depression and anxiety. Your body is a system, not separate parts. Healing one aspect often ripples through everything else.

📚 Read more: https://journals.lww.com/jcge/abstract/2025/05000/psychedelic_assisted_therapy_as_a_promising.2.aspx

Gu tHealth | IBS | ATMA CENA | Holistic Healing

Address

734 42 Avenue SE
Calgary, AB
T2G5N9

Website

Alerts

Be the first to know and let us send you an email when ATMA CENA Practitioners posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category